Peter M. Hecht
2015 - Ironwood Pharmaceuticals
In 2015, Peter M. Hecht earned a total compensation of $4.1M as Chief Executive Officer at Ironwood Pharmaceuticals, a 83% increase compared to previous year.
Compensation breakdown
| Option Awards | $4,017,546 |
|---|---|
| Salary | $100,000 |
| Other | $7,440 |
| Total | $4,124,986 |
Hecht received $4M in option awards, accounting for 97% of the total pay in 2015.
Hecht also received $100K in salary and $7.4K in other compensation.
Rankings
In 2015, Peter M. Hecht's compensation ranked 2,100th out of 13,638 executives tracked by ExecPay. In other words, Hecht earned more than 84.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,100 out of 13,638 | 85th |
Division Manufacturing | 751 out of 5,190 | 86th |
Major group Chemicals And Allied Products | 270 out of 1,854 | 85th |
Industry group Drugs | 212 out of 1,528 | 86th |
Industry Pharmaceutical Preparations | 169 out of 1,182 | 86th |
Source: SEC filing on April 15, 2016.
Hecht's colleagues
We found four more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2015.
2015
Mark Currie
Ironwood Pharmaceuticals
Chief Scientific Officer
2015
Thomas McCourt
Ironwood Pharmaceuticals
Senior Vice President, Marketing and Sales and Chief Commercial Officer
2015
Halley Gilbert
Ironwood Pharmaceuticals
Chief Legal Officer
2015
Tom Graney
Ironwood Pharmaceuticals
Chief Financial Officer
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019